Viridian Therapeutics to Participate in Upcoming May Investor ConferencesBusiness Wire • 15 days agoViridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that...